Four More Chinese Provinces Include ART in Medical Insurance Payment System
The provincial governments of Jiangxi, Shanghai, Qinghai, and Zhejiang have added assisted reproductive technology (ART)...
Policy / Regulatory
China Unveils Ambitious 2024 Medical Reforms with Increased Investment and Policy Reforms
The State Council has issued a notification outlining key medical system reforms for 2024, aiming...
Jiangsu Hengrui Pharmaceuticals Receives FDA Form 483 Following Inspection Discrepancies
The U.S. Food and Drug Administration (FDA) has issued a Form 483 to Jiangsu Hengrui...
China’s NHC Launches Health Literacy Plan to Shift Focus to Preventative Healthcare
China’s National Health Commission (NHC), in collaboration with two other bureaus, has unveiled the “All-Citizen...
China’s NHC Mandates Urban Hospitals to Aid County-Level Medical Institutions
The National Health Commission (NHC) has issued a notification aimed at further promoting the allocation...
China’s NHSA and MoF Plan Expansion of Long-term Care Insurance System Pilot Program
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly issued...
Shenzhen’s Draft Proposal for VBP Drug Procurement and Medical Insurance Fund Management Released
The Healthcare Security Administration (HSA) Bureau of the Shenzhen municipality has released a “Shenzhen Drug...
GenScript Shares Slide on US Congressional Request for FBI Investigation
Shares of GenScript Biotechnology Co., Ltd (HKG: 1548), a China-based Contract Development and Manufacturing Organization...
NMPA Announces Digitalization of Medical Device Regulatory Documents
The National Medical Products Administration (NMPA) has announced a transition to digitalize regulatory documentation for...
China’s NHSA Launches New Procedures for Drug Catalogue Attribution Identification
The National Healthcare Security Administration (NHSA) has issued the “Procedures for Identification of Drug and...
China Unveils Comprehensive Plan to Tackle Unhealthy Practices in Pharma and Healthcare
The National Health Commission (NHC), National Healthcare Security Administration (NHSA), National Medical Products Administration (NMPA),...
Beijing Unveils Action Plan to Boost Pharmaceutical and Health Industry by 2026
The Beijing People’s Government has issued an “Action Plan” outlining measures and targets to “Accelerate...
China’s CDE Issues Draft Guidelines for Patient-Centric Rare Disease Drug R&D
The Center for Drug Evaluation (CDE) has issued a notification regarding the patient-centric rare disease...
China’s NHSA Aims to Boost Medical Insurance Reform with Sanming Model
The National Healthcare Security Administration (NHSA) has issued a notification aimed at promoting the medical...
NMPA Releases 80th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 80th batch of reference drugs for...
Guangzhou Boosts Innovative Drug Development with New HSA Initiatives
The Healthcare Security Administration (HSA) bureau in Guangzhou’s province has issued a notification outlining measures...
China’s NMPA and NHC Tighten Control on Psychotropic Substances with New Regulations
The National Medical Products Administration (NMPA) and the National Health Commission (NHC) of China have...
FDA Alert: Chinese Syringe Maker Jiangsu Shenli Initiates Voluntary Recall
This week, the US Food and Drug Administration (FDA) provided a status report on its...
China’s CDE Reports Record High in Clinical Trials for Innovative Drugs in 2023
The Center for Drug Evaluation (CDE) has released its annual report, highlighting the growth in...
NHSA Unveils 2024 Medical Procurement Overhaul, Aiming for Synergy Between National and Provincial Levels
The National Healthcare Security Administration (NHSA) has issued a notification detailing plans to enhance the...